Versa Vascular, developer of a novel transcatheter tricuspid valve repair system—AdapTR—has announced changes to its senior management team and the completion of new investment to support clinical study of its device. The company announced that Bill Shields, a former vice president and general manager of Medtronic’s Transcatheter Mitral and Tricuspid Therapies division joins as CEO, […] The post Medtronic executive Shields appointed CEO at Versa Vascular appeared first on Cardiovascular News .